US HB4053 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on June 13 2023 - 25% progression
Action: 2023-06-16 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 13 2023 - 25% progression
Action: 2023-06-16 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To provide for the review of the scheduling under the Controlled Substances Act of buprenorphine-naloxone combination products, and for other purposes.
Title
Studying Suboxone Act
Sponsors
| Rep. Ann Kuster [D-NH] | Rep. Earl Carter [R-GA] | Rep. Paul Tonko [D-NY] | Rep. Marcus Molinaro [R-NY] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-06-16 | House | Referred to the Subcommittee on Health. |
| 2023-06-13 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2023-06-13 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/4053/all-info |
| Text | https://www.congress.gov/118/bills/hr4053/BILLS-118hr4053ih.pdf |
